A Volumetric Intravascular Ultrasound Comparison of Early Drug-Eluting Stent Thrombosis Versus Restenosis

JACC: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 428-434

  Liu, Xuebo ^a,b   Doi, Hiroshi ^a,b   Maehara, Akiko ^a,b   Mintz, Gary S ^a,b   de Ribamar Costa Jr , Jose ^a,b   Sano, Koichi ^a,b   Weisz, Giora ^a,b   Dangas, George D ^a,b   Lansky, Alexandra J ^a,b   Kreps, Edward M ^a,b   Collins, Michael ^a,b   Fahy, Martin ^b   Stone, Gregg W ^a,b   Moses, Jeffrey W ^a,b   Leon, Martin B ^a,b   Mehran, Roxana ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

in stent restenosis; intravascular ultrasound; stent expansion; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; FEMALE; HUMAN; IMAGE ANALYSIS; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; MALE; PRIORITY JOURNAL; STENT THROMBOSIS; VOLUMETRY; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; CORONARY RESTENOSIS; CORONARY THROMBOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; TIME;

ANALYSIS OF VARIANCE; ASPIRIN; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 65549101187     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.01.011     Document Type: Article

References (31)

1. Sousa J.E., Costa M.A., Abizaid A., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 (2001) 192-195
2. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
3. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
4. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
5. Kastrati A., Mehilli J., von Beckerath N., et al. Sirolimus-eluting stents or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
6. Jeremias A., Sylvia B., Bridges J., et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109 (2004) 1930-1932
7. Uren N.G., Schwarzacher S.P., Metz J.A., et al. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J 23 (2002) 124-132
8. Fujii K., Carlier S.G., Mintz G.S., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
9. Cheneau E., Leborgne L., Mintz G.S., et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 108 (2003) 43-47
10. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K.L., Agostino R.D., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
11. Kasaoka S., Tobis J.M., Akiyama T., et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 32 (1998) 1630-1635
12. Lemos P.A., Saia F., Ligthart J.M., et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation 108 (2003) 257-260
13. Mintz G.S. Mechanisms, prevention, and treatment of restenosis. In: Mintz G.S. (Ed). Intracoronary Ultrasound (2005), Taylor and Francis, London 299-400
14. Takebayashi H., Kobayashi Y., Mintz G.S., et al. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol 95 (2005) 498-502
15. Hong M.K., Mintz G.S., Lee C.W., et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 1305-1310
16. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
17. Sonoda S., Morino Y., Ako J., et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 43 (2004) 1959-1963
18. Strony J., Beaudoin A., Brands D., and Adelman B. Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol 265 (1993) H1787-H1796
19. Stone P.H., Coskun A.U., Kinlay S., et al. Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans. In vivo 6-month follow-up study. Circulation 108 (2003) 438-444
20. Carlier S.G., van Damme L.C., Blommerde C.P., et al. Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation. Inhibition through reduction of inflammation?. Circulation 107 (2003) 2741-2746
21. Sukavaneshvar S., Rosa G.M., and Solen K.A. Enhancement of stent-induced thromboembolism by residual stenoses: contribution of hemodynamics. Ann Biomed Eng 28 (2000) 182-193
22. Moreno P.R., Murcia A.M., Palacios I.F., et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 102 (2000) 2180-2184
23. Creager M.A., Luscher T.F., Cosentino F., and Beckman J.A. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108 (2003) 1527-1532
24. Farb A., Burke A.P., Kolodgie F.D., and Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-1706
25. Chieffo A., Bonizzoni E., Orlic D., et al. Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents. Circulation 109 (2004) 2732-2736
26. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation if antiplatelet therapy. Lancet 364 (2004) 1519-1521
27. Kahn J. Restenosis, thrombosis, and cost debated at DES symposium. J Inter Cardiol 18 (2005) 291-294
28. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
29. Cook S., Wenaweser P., Togni M., et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
30. Shah V.M., Mintz G.S., Apple S., and Weissman N.J. Background incidence of late malapposition after bare-metal stent implantation. Circulation 106 (2002) 1753-1755
31. de Ribamar Costa Jr. J., Mintz G.S., Carlier S.G., et al. Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol 100 (2007) 812-817